Key result
PPCM requires standard HF therapy with special provisions for pregnant and lactating women.
Peripartum cardiomyopathy is a potentially devastating disease requiring a high index of suspicion for diagnosis and standard heart failure treatment with special provisions for pregnant and lactating women.
No takes yet. Share an insight, caveat, or question.
Emphasizes tailored HF management for peripartum cardiomyopathy during pregnancy and lactation; leaves open etiology and targeted therapies.
Blauwet et al. (2011) conducted a review in Peripartum cardiomyopathy. Peripartum cardiomyopathy is a challenging disease with unclear etiology and varied clinical course that requires standard heart failure treatment with special provisions for pregnant and lactating women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: